Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
| Autor: | Koji Masui, Hideya Yamazaki, Yoshiaki Ota, Gen Suzuki, Kei Yamada |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0106 biological sciences
medicine.medical_specialty Palliative care medicine.medical_treatment Brachytherapy brachytherapy Case Report 01 natural sciences head and neck neoplasms Tongue medicine Radiology Nuclear Medicine and imaging Local anesthesia palliative care business.industry image-guided brachytherapy 010401 analytical chemistry Head and neck cancer Cancer medicine.disease Single fraction High-Dose Rate Brachytherapy 0104 chemical sciences medicine.anatomical_structure Oncology Medicine Radiology business 010606 plant biology & botany |
| Zdroj: | Journal of Contemporary Brachytherapy, Vol 12, Iss 3, Pp 273-278 (2020) Journal of Contemporary Brachytherapy |
| ISSN: | 2081-2841 |
| Popis: | Purpose To present a small series of cases, in which single-fraction image-guided high-dose-rate (HDR) brachytherapy was provided as palliative treatment for inoperable head and neck cancer cases. Material and methods We used this technique to treat 3 patients with symptomatic head and neck cancer (tongue cancer, gingival metastasis of osteosarcoma, and external auditory canal cancer), who were not eligible for a definitive treatment. The purpose of palliative brachytherapy in all 3 patients was the relief of symptoms such as difficulty in eating, talking, and hearing. All patients were treated with computed tomography (CT) image-guided interstitial HDR brachytherapy under local anesthesia in an outpatient setting, with a single dose of 10 Gy. Results Satisfactory palliative effects were achieved in all cases without serious side effects. The palliative effects were sustained in 2 patients until death, and 1 patient lived for 39 weeks before a relapse. Conclusions Our palliative treatment technique appears to be safe, effective, and less invasive, and could be a treatment option for symptomatic patients with head and neck cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|